EUVIMEDEUVIMED entdecken
Crossref

Synergistic Sulfur‐Atom Positioning and Acceptor Engineering Enable Preferential Type‐I Photodynamic Therapy

Junhui Liu iD, Mengna Xie, Tianxin Yang, Tenghui Wang, Xinyu Zhang, Qinhong Jiang, Panfei Xing iD

Advanced Healthcare Materials · 08.11.2026

DOI: 10.1002/adhm.71966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.11.2026. Verfasst von Junhui Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Kaifeng, China. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Double First-Class Initiative Construction Project of Henan University, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Less oxygen‐independent Type‐I reactive oxygen species (ROS) generated by photosensitizers offer distinct advantages for tumor photodynamic therapy (PDT). However, most conventional photosensitizers activate nonselective mixed ROS pathways, significantly hindering the advancement of PDT. In this study, we propose a synergistic molecular design strategy that integrates sulfur‐atom positioning and acceptor engineering to achieve preferential Type‐I ROS generation. We identified a novel near‐infrared Type‐I photosensitizer NS4 . Combined theoretical calculations and experimental characterizations demonstrate that sulfur substitution enhances the S 1 ‐T 1 intersystem crossing, while acceptor engineering promotes a pronounced twisted intramolecular charge transfer (TICT). This TICT effect lowers the energy of the S 1 state and stabilizes the T 1 state, thereby synergistically enabling the preferential production of Type‐I ROS. Both free NS4 derivative and NS‐NPs , self‐assembled from NS4 and F‐127, can generate substantial amounts of Type‐I ROS under 660 nm laser irradiation, effectively triggering tumor cell apoptosis. In vivo assessments confirm that a single dose of NS‐NPs significantly suppresses tumor growth with negligible systemic toxicity. This work establishes theoretical and structural guidelines for the rational design of high‐performance Type‐I photosensitizers and facilitates the further translation of PDT.

Schlagwörter

Stichwörter der Autor:innen

PDTType‐I ROSacceptor engineeringintersystem crossingsulfur‐atom positioning

Autor:innen und Institutionen

  • Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Kaifeng, China.

ORCID-Profile: Junhui Liu, Panfei Xing

Förderung

  • Double First-Class Initiative Construction Project of Henan University
  • China Postdoctoral Science Foundation

Zitieren

APA

Liu, J., Xie, M., Yang, T., Wang, T., Zhang, X., Jiang, Q., & Xing, P. (2026). Synergistic Sulfur‐Atom Positioning and Acceptor Engineering Enable Preferential Type‐I Photodynamic Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71966

Vancouver

Liu J, Xie M, Yang T, Wang T, Zhang X, Jiang Q, et al. Synergistic Sulfur‐Atom Positioning and Acceptor Engineering Enable Preferential Type‐I Photodynamic Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71966

BibTeX
@article{Liu2026,
  author = {Liu, Junhui and Xie, Mengna and Yang, Tianxin and Wang, Tenghui and Zhang, Xinyu and Jiang, Qinhong and Xing, Panfei},
  title = {Synergistic Sulfur‐Atom Positioning and Acceptor Engineering Enable Preferential Type‐I Photodynamic Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71966}
}
Kostenlos starten →